Hussman Strategic Advisors, Inc. Novo Nordisk A S Call Options Transaction History
Hussman Strategic Advisors, Inc.
- $428 Million
- Q3 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NVO
# of Institutions
1,685Shares Held
286MCall Options Held
14.8MPut Options Held
22M-
Bank Of America Corp Charlotte, NC14.7MShares$724 Million0.08% of portfolio
-
Morgan Stanley New York, NY14.3MShares$702 Million0.07% of portfolio
-
Loomis Sayles & CO L P12.6MShares$618 Million1.12% of portfolio
-
Capital International Investors Los Angeles, CA11.6MShares$571 Million0.14% of portfolio
-
Fayez Sarofim & CO Houston, TX10.5MShares$516 Million1.8% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $111B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...